Human hepatocyte growth factor (hHGF) has recently been expressed as a recombinant polypeptide from Chinese hampster ovary cell transfectants. Using a primary rat hepatocyte bioassay, we have tested the biological activity of recombinant hHGF and compared it with native hHGF. Dose-response curves were almost identical, with half-maximal stimulation of DNA synthesis at 1-2 ng/ml (equivalent to -10 pM
Introduction
Human hepatocyte growth factor (hHGF)l is a polypeptide of mol wt -85,000-90,000 first identified in the plasma of pa-1. Abbreviations used in this paper: FHF, fulminant hepatic failure; hHGF, human hepatocyte growth factor; HPTA, hepatopoeitin A; KRB, Krebs ringer bicarbonate buffer.
tients with fulminant hepatic failure (FHF) and found to stimulate DNA synthesis in adult rat hepatocytes (1, 2) . We have recently cloned the factor and reported the deduced 728 amino acid sequence which includes a putative amino terminal signal peptide (3). Nakamura et al. also recently cloned hHGF c-DNA yielding a sequence that differed by 14 amino acids (4) . hHGF is translated from a full length mRNA of -6 kb, with a single protease cleavage site yielding two polypeptide chains of mol wt -30,000 and 60,000 linked by probably one disulphide bridge (3, 4) . Rat HGF has also recently been cloned and sequenced (5, 6 ) and a partial amino acid sequence of the rabbit-derived hepatopoeitin A (HPTA) reported (7), indicating close species homology between these factors.
We have shown a direct correlation between circulating levels of hHGF as measured by rat hepatocyte bioassay and the grade ofhepatic encephalopathy in patients with FHF (8) . Notably, the level was reduced to near normal in patients who had recovered from the disease (8) . More recently, using a highly specific ELISA technique, these findings have been confirmed indicating a 30-fold rise in circulating hHGF in the FHF group (9) . The tissue responsible for synthesis and release ofthis activity however is not known. Although increases were seen in other patient groups such as acute hepatitis, the differences (< 2-fold) were small when compared with the large increase seen in FHF (9) .
In experimental animals, HGF expression has been found in a variety of tissues including the liver, but some species differences in the pattern ofexpression are reported (5, 10) . Serum levels of HGF/HPTA rise after partial hepatectomy in the rat (1 1, 12), although the major sites of synthesis and release during liver regeneration have not yet been identified. However, HGF does rise in the damaged liver tissue ofrats after administration of D-galactosamine or CC14 (6, 13) . Thus, raised levels of HGF appear to be associated with conditions where after surgical resection or massive acute hepatic damage the requirement for hepatic regeneration is likely to be high.
While a wide range of hormones and growth factors have been implicated in the regulation of liver regeneration in vivo ( 14) , the role of HGF has yet to be fully characterized. In vitro studies from several laboratories indicate HGF to be a potent growth promoter of rat hepatocytes and to act through a unique plasma membrane receptor (2, 15) . To further examine its relevance as a physiological hepatotrophic factor, in this study, we report the successful expression of recombinant hHGF and compare its potency with purified native hHGF using rat hepatocytes. Additionally, we have compared growth promoting bioactivity ofthe two HGF preparations on normal adult human hepatocytes.
Methods
Preparation of native hHGF. Native hHGF was purified from the plasma of patients with fulminant hepatic failure as previously described (1, 2 (19) .
Preparation ofadult human hepatocytes. Normal human liver tissue was obtained from segments surgically removed from adult donor organs before reduced-graft transplant into pediatric recipients. Tissue had been perfused free of blood with University of Wisconsin preservation fluid (20) and maintained at 4°C for 12-24 h before cell isolation.
Hepatocytes were isolated by enzyme perfusion originally described for use with human liver by Strom et al. (21) with several modifications. Two exposed vessels on the single cut surface of 100-200 g segments from the right or the left lobe were cannulated with 3 mm internal diameter tubing. Other major vessels were sutured and the tissue was perfused at 50 ml/min sequentially with 750 ml Ca2+/Mg2+-free Krebs ringer bicarbonate buffer containing 10 mM Hepes (KRB), 1500 ml 0.5 mM EGTA in KRB and 750 ml KRB. Perfusates were allowed to run to waste. Finally, 200 ml enzyme solution (0.05% collagenase, 0.05% hyaluronidase, 0.1% dispase, 0.005% DNAase containing 5 mM CaC12) was perfused with recirculation and enzymatic digestion continued for 30-45 min until the liver was judged to be substantially softened. The tissue was then minced with scissors in 500 ml KRB, containing CaCl2 and 10% FCS, stirred for 10 min, and the cell suspension filtered through 60 ,sm nylon mesh. Cells were washed 3x in KRB/ CaCl2/10% FCS by centrifugation at 50 g, and viability and yield assessed by trypan blue exclusion and haemocytometer counting. All solutions were supplemented with 100 U/ml pencillin and 100 ,g/ml streptomycin, were pregassed with 95% OJ5% C02, and maintained at 370C throughout.
Culture ofhepatocytes. Rat and human hepatocytes were plated on rat-tail tendon collagen-coated 35 mm tissue culture dishes (22) in 2 ml ofKRB/CaC lI0% FCS (1.5 X I05 and 3 X I05 cells/ml, respectively). After 60 min, attached cells were washed 2 X PBS and were refed with arginine-free Williams' E medium supplemented with 0.4 mM ornithine, 100 nM insulin, 5.5 uM hydrocortisone, 100 U/ml penicillin, and 100 ,g/ml streptomycin without serum (19 (Fig. 1) . These molecular weights correspond to native hHGF which we reported previously (2) and both showed hHGF activity. The apparent heterogeneity of recombinant hHGF may be due to differences in glycosylation. Under reducing conditions, the two bands separated into four of mol wt 62,800 and 58,100 corresponding to the heavy chain and mol wt 34,300 and 31,800 corresponding to the light chain (Fig. 1) .
Stimulation ofDNA synthesis in rat hepatocytes by hHGF.
The bioactivity of recombinant hHGF was tested by its ability to stimulate [3H]-thymidine incorporation into normal adult rat hepatocytes and compared directly with a preparation of native hHGF. As shown in Fig. 2 , the dose-response curves for native and recombinant were almost identical with significant increases from 0.63 ng/ml and reaching maximal activity at 10 ng/ml. Solvent controls (addition of0.2% or 1% BSA for native and recombinant hHGF groups, respectively) gave rates of incorporation no higher than with basal medium (results not shown). The S-phase labeling index showed a similar pattern of incorporation (Fig. 3) Table I . Viability ofpreparations was consistently 80% or above. Although the yield/g wet wt tissue was relatively low, the amount of liver tissue perfused gave total yields in excess of I09 cells. Fig. 4 shows a typical dose-response curve of native and recombinant hHGF on human hepatocyte DNA synthesis. Although the overall rate of basal [3H]-thymidine incorporation into DNA was lower than seen in rat cells (Figs. 2 and 4) , reflected also by a lower basal S-phase labeling index (Figs. 3  and 5 ), the degree of stimulation by HGF was similar. Moreover, human hepatocytes appeared more sensitive to hHGF than rat cells with half-maximal stimulatory concentration of native and recombinant hHGF on human hepatocytes (0.6 ng/ ml and 0.3 ng/ml, respectively) consistently lower than rat cells (-2 ng/ml). These observations were confirmed by autoradiography and determination of S-phase labeling index (Fig. 5 ) with maximal stimulation (up to 20%) of labeled cells occurring at 1.2 ng/ml recombinant hHGF and at 5 ng/ml native hHGF.
Discussion
Previous studies have shown that purified native hHGF can stimulate DNA synthesis in primary cultures ofrat hepatocytes (19, 23, 24) , on a molar basis hHGF is, therefore, the most potent growth factor for isolated hepatocytes yet described. The presence of numerous mitotic cells also indicates that HGF is capable of acting as a true mitogenic factor. HGF can, therefore, be considered as a primary mitogen (25) since it retains full biological activity in the absence of other growth factors. Our recent investigations using normal adult human hepatocyte cultures have indicated that they retain biological responsiveness to several ofthe factors known to be active on rat cells, including EGF, TGFa, and TGF# (26) . However, important species differences have become apparent. For example AVP, which in the rat can enhance hepatocyte DNA synthesis both in vitro and in vivo (27, 28) , fails to stimulate DNA synthesis in human hepatocytes, either alone or in the presence of other growth factors (29) . Further studies revealed few if any functional V1 type specific AVP receptors present in human liver plasma membrane preparations or on freshly isolated hepato- cytes (30) . Specific VI type receptors are also absent from rabbit liver (31) . These observations highlight the care required when extrapolating from animal studies to the human situation, and emphasize the importance ofthe work described here using normal human hepatocytes in establishing the identity of the factors that may be of physiological relevance in control of human liver regeneration. The availability ofa bioactive recombinant human hepatocyte growth factor has important implications in the study of liver growth in vivo. Firstly, in vivo infusion studies are now feasible in order to test its biological activity in the intact, partially hepatectomized or hepatotoxin-treated animal. Secondly, it provides impetus to the possibility of manipulating the regenerative process in vivo and, therefore, providing a potential clinical therapeutic application. However, full regeneration of functional liver tissue requires not just expansion ofthe hepatocyte population, but growth of the other cell types present in the liver and deposition of extracellular matrix components, to form correct lobular architecture. Clearly the control mechanisms are complex and critically regulated and are therefore also likely to involve more than one individual factor. The demonstration in regenerating liver tissue of increased expression of several other factors capable of modulating cell growth and differentiation, including TGFa, aFGF, and TGFj3 (23, 24, 32, 33 ) reinforces this conclusion.
Although HGF expression in the liver does occur, it is not confined to this organ and its presence in other tissues both at the protein and mRNA levels has been shown (5, 6, 10) . The question, therefore, of whether intra-or extra-hepatic sources are responsible for the elevated circulating levels of HGF during hepatic regeneration (1 1, 12) has not yet been resolved. Nevertheless the ability ofHGF to stimulate hepatocyte growth in the absence of other growth factors and the potency in vitro demonstrated here, suggest that it may make an important contribution to control of the growth process in vivo.
